Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study

@article{Drks2013AntidepressantDU,
  title={Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study},
  author={M. D{\"o}rks and I. Langner and U. Dittmann and A. Timmer and E. Garbe},
  journal={European Child & Adolescent Psychiatry},
  year={2013},
  volume={22},
  pages={511-518}
}
  • M. Dörks, I. Langner, +2 authors E. Garbe
  • Published 2013
  • Medicine
  • European Child & Adolescent Psychiatry
  • The off-label use of drugs in children and adolescents is widespread. In Germany, the use of selective serotonin reuptake inhibitors (SSRIs) and other antidepressants (OADs) is not licensed for the treatment of depressive disorders in children and adolescents except for fluoxetine, which was approved in 2006. Against this background, antidepressant drug (ATD) use with a particular focus on off-label prescribing was characterised in a retrospective cohort study including cross-sectional analyses… CONTINUE READING
    34 Citations
    Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005–2012
    • 89
    • PDF
    Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011
    • 17

    References

    SHOWING 1-10 OF 23 REFERENCES
    Antidepressant use in children and adolescents in Germany.
    • 95
    ["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].
    • 10
    Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns.
    • 35
    • Highly Influential
    Antidepressant use and off‐label prescribing in children and adolescents in Dutch general practice (2001–2005)
    • 58
    • PDF